`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`TARO PHARMACEUTICALS U.S.A., INC.,
`Petitioners,
`
`v.
`
`APOTEX TECHNOLOGIES INC.,
`Patent Owner.
`________________
`
`Case IPR2017-01446
`U.S. Patent No. 7,049,328
`________________
`
`
`DECLARATION OF BARRY P. GOLOB IN SUPPORT OF MOTION FOR
`ADMISSION PRO HAC VICE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`I, Barry P. Golob, declare as follows:
`
`IPR2017-01446
`U.S. Patent No. 7,049,328
`Declaration of Barry P. Golob
`
`1. I am currently Co-Chair of Cozen O’Connor’s Intellectual Property
`
`Litigation Group with supervisory authority over Cozen O’Connor patent
`
`litigations. I have been practicing law for 27 years. For more than 25 years, my
`
`practice has focused primarily on patent litigation in the life sciences.
`
`2. I was admitted to the State of Pennsylvania Bar in 1991 and the District of
`
`Columbia Bar in 1993. I am a member in good standing of both Bars.
`
`3. I have been admitted and am a member of good standing of the following
`
`courts: U.S. District Court for the Eastern District of Texas, U.S. District Court for
`
`the District of Colorado, U.S. Court of Appeals for the District of Columbia, U.S.
`
`Court of Appeals for the Federal Circuit, U.S. Court of Federal Claims, and the
`
`U.S. Supreme Court.
`
`4. I have never been suspended or disbarred from practice before any court
`
`or administrative body.
`
`5. I have never had a court or administrative body deny my application for
`
`admission to practice.
`
`6. I have never had any sanctions or contempt citations imposed by any
`
`court or administrative body.
`
`7. I have read and will comply with the Patent Office Trial Practice Guide
`
`and the Board’s Rules for Practice for Trials, as set forth in 37 C.F.R. Part 42.
`
`2
`
`
`
`8. I agree to be subject to the United States Patent and Trademark Office
`
`IPR2017-01446
`U.S. Patent No. 7,049,328
`Declaration of Barry P. Golob
`
`
`
`Rules of Professional Conduct set forth in 37 C.F.R. §§ 11.101 et seq. and
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a).
`
`9. I have not appeared Pro Hac Vice before the Patent Trial and Appeal
`
`Board.
`
`10. In addition to this matter, I represent ApoPharma Inc., ApoPharma USA,
`
`Inc., and Apotex Technologies Inc. in a U.S. District Court litigation before the
`
`United States District Court for the Eastern District of Texas Marshall Division
`
`civil action no. 2:16-cv-00528-RSP concerning U.S. Patent No. 7,049,328.
`
`11. As lead counsel in the U.S. District Court litigation before the United
`
`States District Court for the Eastern District of Texas Marshall Division civil
`
`action no. 2:16-cv-00528-RSP concerning U.S. Patent No. 7,049,328, I am familiar
`
`with subject matter related to cardiac iron chelation technology. Moreover, I have
`
`represented a number of life science and pharmaceutical companies in many patent
`
`litigation matters before federal district and appellate courts. In particular, I have
`
`extensive experience litigating highly specialized Hatch-Waxman actions
`
`involving prescription pharmaceutical drugs.
`
`
`
`12. I hereby declare that all statements made herein of my own knowledge
`
`are true and that all statements made on information and belief are believed to be
`
`true; and further that these statements are made with the knowledge that willful
`
`3
`
`
`
`
`false statements and the like are punishable by fine, imprisonment, or both under
`
`IPR2017-01446
`U.S. Patent No. 7,049,328
`Declaration of Barry P. Golob
`
`Section 1001 of Title 18 of the United States Code.
`
`
`
`
`
`
`
`
`
`Dated: April 17, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`/Barry P. Golob/
`Barry P. Golob
`
`
`COZEN O’CONNOR PC
`1200 Nineteenth St. N.W.
`Washington, D.C. 20036
`202-912-4815
`bgolob@cozen.com
`
`4
`
`